Detalhe da pesquisa
1.
Bacterial Outer Membrane Vesicles as a Platform for the Development of a Broadly Protective Human Papillomavirus Vaccine Based on the Minor Capsid Protein L2.
Vaccines (Basel)
; 11(10)2023 Oct 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37896984
2.
Immunogenicity of Escherichia coli Outer Membrane Vesicles: Elucidation of Humoral Responses against OMV-Associated Antigens.
Membranes (Basel)
; 13(11)2023 Nov 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37999368
3.
Anti-Tumor Efficacy of In Situ Vaccination Using Bacterial Outer Membrane Vesicles.
Cancers (Basel)
; 15(13)2023 Jun 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37444437
4.
Immunogenicity and pre-clinical efficacy of an OMV-based SARS-CoV-2 vaccine.
Res Sq
; 2023 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37292970
5.
Immunogenicity and Pre-Clinical Efficacy of an OMV-Based SARS-CoV-2 Vaccine.
Vaccines (Basel)
; 11(10)2023 Sep 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37896949
6.
Outer Membrane Vesicles From The Gut Microbiome Contribute to Tumor Immunity by Eliciting Cross-Reactive T Cells.
Front Oncol
; 12: 912639, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35847919